Matches in SemOpenAlex for { <https://semopenalex.org/work/W2497697735> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2497697735 endingPage "143" @default.
- W2497697735 startingPage "134" @default.
- W2497697735 abstract "Introduction Treatment strategies of de novo symptomatic multiple myeloma (MM) are mainly related to age and comorbidity. Patients <65 years of age without major organ dysfunction (renal, liver, heart and lung) are eligible for intensive chemotherapy and ASCT[1]. The goal of this approach is to obtain a durable complete remission and long-term disease control. A reduced-intensity conditioning regimen followed by ASCT may be also used in patients aged 65–70, or younger patients with pre-existing comorbidities[2]. Patients older than 65 and those who are ineligible for transplantation are candidates for melphalan–prednisone (MP)-based chemotherapy in combination with the new drugs thalidomide, bortezomib and lenalidomide [2]. Risk stratification in multiple myeloma Multiple myeloma is a heterogeneous disease with variable clinical presentation and prognosis with a survival outcome that ranges from one year in a patient with aggressive disease to ten years in a patient with indolent disease presentation. Evaluation of prognostic factors and risk stratification is important to define appropriate treatment strategies. There is consensus that the current risk stratification is applicable to newly diagnosed patients: a report of the International Myeloma Workshop consensus panel suggested the following parameters: serum beta2 microglobulin and albumin (ISS stage), cytogenetic translocation determined by fluorescent in situ hybridization (FISH) analysis [t(4;14), t(14;16), del(17p)], LDH, immunoglobulin type IgA and histology of plasmablastic disease. Additional analyses for risk stratification are conventional cytogenetics, gene expression profiling, labeling index, MRI/PET scan and DNA copy number alterations by CGH/SNP array[3]. There is a general agreement that risk stratification should be a global stratification and that the risk factors will change in the future with introduction of novel agents and combination therapies." @default.
- W2497697735 created "2016-08-23" @default.
- W2497697735 creator A5002972322 @default.
- W2497697735 creator A5017455719 @default.
- W2497697735 creator A5059967673 @default.
- W2497697735 creator A5080712446 @default.
- W2497697735 date "2013-12-18" @default.
- W2497697735 modified "2023-09-26" @default.
- W2497697735 title "Multiple myeloma: management of de novo disease to include HDT" @default.
- W2497697735 doi "https://doi.org/10.1017/cbo9780511862465.011" @default.
- W2497697735 hasPublicationYear "2013" @default.
- W2497697735 type Work @default.
- W2497697735 sameAs 2497697735 @default.
- W2497697735 citedByCount "0" @default.
- W2497697735 crossrefType "book-chapter" @default.
- W2497697735 hasAuthorship W2497697735A5002972322 @default.
- W2497697735 hasAuthorship W2497697735A5017455719 @default.
- W2497697735 hasAuthorship W2497697735A5059967673 @default.
- W2497697735 hasAuthorship W2497697735A5080712446 @default.
- W2497697735 hasConcept C126322002 @default.
- W2497697735 hasConcept C143998085 @default.
- W2497697735 hasConcept C2776063141 @default.
- W2497697735 hasConcept C2776364478 @default.
- W2497697735 hasConcept C2776694085 @default.
- W2497697735 hasConcept C2777478702 @default.
- W2497697735 hasConcept C2778336483 @default.
- W2497697735 hasConcept C2778684742 @default.
- W2497697735 hasConcept C2779050716 @default.
- W2497697735 hasConcept C2779609412 @default.
- W2497697735 hasConcept C2911091166 @default.
- W2497697735 hasConcept C71924100 @default.
- W2497697735 hasConceptScore W2497697735C126322002 @default.
- W2497697735 hasConceptScore W2497697735C143998085 @default.
- W2497697735 hasConceptScore W2497697735C2776063141 @default.
- W2497697735 hasConceptScore W2497697735C2776364478 @default.
- W2497697735 hasConceptScore W2497697735C2776694085 @default.
- W2497697735 hasConceptScore W2497697735C2777478702 @default.
- W2497697735 hasConceptScore W2497697735C2778336483 @default.
- W2497697735 hasConceptScore W2497697735C2778684742 @default.
- W2497697735 hasConceptScore W2497697735C2779050716 @default.
- W2497697735 hasConceptScore W2497697735C2779609412 @default.
- W2497697735 hasConceptScore W2497697735C2911091166 @default.
- W2497697735 hasConceptScore W2497697735C71924100 @default.
- W2497697735 hasLocation W24976977351 @default.
- W2497697735 hasOpenAccess W2497697735 @default.
- W2497697735 hasPrimaryLocation W24976977351 @default.
- W2497697735 hasRelatedWork W1776089447 @default.
- W2497697735 hasRelatedWork W1899693826 @default.
- W2497697735 hasRelatedWork W1963598564 @default.
- W2497697735 hasRelatedWork W1969282676 @default.
- W2497697735 hasRelatedWork W1998147039 @default.
- W2497697735 hasRelatedWork W2084594085 @default.
- W2497697735 hasRelatedWork W2121283512 @default.
- W2497697735 hasRelatedWork W2164357850 @default.
- W2497697735 hasRelatedWork W22070422 @default.
- W2497697735 hasRelatedWork W2407721796 @default.
- W2497697735 hasRelatedWork W2414550021 @default.
- W2497697735 hasRelatedWork W2425909334 @default.
- W2497697735 hasRelatedWork W2887448109 @default.
- W2497697735 hasRelatedWork W2892318752 @default.
- W2497697735 hasRelatedWork W2893245372 @default.
- W2497697735 hasRelatedWork W3027347745 @default.
- W2497697735 hasRelatedWork W3032603927 @default.
- W2497697735 hasRelatedWork W3034037943 @default.
- W2497697735 hasRelatedWork W3198246197 @default.
- W2497697735 hasRelatedWork W37180177 @default.
- W2497697735 isParatext "false" @default.
- W2497697735 isRetracted "false" @default.
- W2497697735 magId "2497697735" @default.
- W2497697735 workType "book-chapter" @default.